Status Migrenozus: Tanı ve Tedavisi

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211.

Arruda MA, Guidetti V, Galli F, et al. Pediatric migrene: clinical features and comorbidities. Neurol Sci. 2013;34 (Suppl 1): 47-51.

Kacperski J, Schoenen J. Pediatric migrene. Handb Clin Neurol. 2015;133:449-468.

Burstein, R., Noseda, R., & Borsook, D. (2015). Migraine: Multiple processes, complex pathophysiology. The Journal of Neuroscience.

Goadsby, P. J., et al. (2017). Pathophysiology of migraine: A disorder of sensory processing. Physiological Reviews.

Edvinsson, L., et al. (2018). CGRP as the target of new migraine therapies. The Lancet Neurology.

Pietrobon D, Moskowitz MA. Pathophysiology of migrene. Annu Rev Physiol. 2013;75:365-391.

Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in childhood migrenes: clinical impact and comparison to other chronic illnesses. Pediatrics. 2017;135(6):e1532-1541.

Silberstein SD, Tfelt-Hansen P. Handbook of Headache. 3rd ed. 2016.

Tasdemir HA, Karadeniz D, Özkale Y. Status migrenozus in pediatric population: a case series and review. Turk J Pediatr. 2020;62(2):216-224.

Abu-Arafeh I, Razak S, Sivaraman B, et al. Prevalence of headache and migrene in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088-1097.

Lewis DW, Ashwal S, Hershey AD, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents. Neurology. 2004;63:2215–2224.

Hershey AD, Powers SW, Vockell AL, et al. Effectiveness of intravenous valproate as an acute treatment for pediatric migraine. Headache. 2004;44:62–69.

Pakalnis A, Kring D. Acute treatment of pediatric status migrainosus. Headache. 2002;42:64–69.